Identification of Possible Blood Based Breast Cancer Biomarkers

Amritha S

$76.95 $65.44

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

RUBIOUS SHMS LTD
11 November 2023

Oncology; Nursing specialties; Coping with illness

Summary
Details

Breast cancer (BC) is the most common malignancy worldwide and accounts for 11.7% among all cancers in both the sexes, with an annual incidence of 2.3 million. BC is the leading malignancy in 159 of 185 countries and has an increasing trend in incidence from 1996-2018. Moreover, there is an 88% higher incidence in transitioned countries than the transitioning countries (55.9 and 29.7 per 100,000, respectively). The American cancer society has estimated an incidence of 287,850 invasive BC and 51,400 of non-invasive BC in US for the year 2022. The incidence of BC has increased not only due to the change in risk factor profiles but also because of reduced screening and delayed first treatments due COVID-19.

Besides being the most prevalent, BC remains as leading cause of cancer deaths among women worldwide with a mortality rate of 684,996 [95% UI, 675,493-694,633]. Cancer Facts & Figures 2022 from the American Cancer Society predicted a mortality rate of 43,250 in the US. Although the BC incidence rates were highest in developed regions, their 5-year survival rates for localised and regional BC were 89.6% and 75.4% as opposed to the developing countries in like Costa Rica, India, Philippines, and Thailand which showed survival of 76.3% for localised and 47.4% for regional BC.

BC in Indian females accounts for 8.2% of all cancers; the age standardised incidence rate of female BC increased by 39-1% (95% UI 5-1-85-5) during 1990 to 2016. India reflects a culturally diverse country with varying degrees of development, lifestyle and diet leading to a heterogeneous distribution of disease burden. As per the global burden initiative report the age-standardised incidence rate of BC varied 3-2 times across the Indian states. In India, majority of patients present at locally advanced or at metastatic stages at the time of diagnosis. The constant increase and variations in BC occurrence might be due to the lack of early detection screening strategies, low outreach of existing diagnostic measures and interplay of various risk factors associated with the disease.

By: Amritha S
Imprint: RUBIOUS SHMS LTD
Country of Publication: United Kingdom
Dimensions: Height: 279mm, Width: 216mm, Spine: 11mm
Weight: 494g
ISBN: 9781835800522
ISBN 10: 1835800521
Pages: 208
Publication Date: 11 November 2023
Audience: General/trade , ELT Advanced
Format: Paperback
Publisher's Status: Active